Current Treatment Trends in Fabry Disease

被引：0
|
作者：
Linthorst, Gabor [1 ]
机构：
[1] Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands
来源：
CLINICAL THERAPEUTICS | 2009年 / 31卷
关键词：
ENZYME REPLACEMENT THERAPY; HUMAN ALPHA-GALACTOSIDASE; AGALSIDASE-BETA; TRIAL; EFFICACY; SAFETY;
D O I：
10.1016/S0149-2918(09)00245-8
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [21] Fabry disease: genetics, pathology, and treatment
    Bernardes, Thaiza Passaglia
    Foresto, Renato Demarchi
    Kirsztajn, Gianna Mastroianni
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2020, 66 : S10 - S16
  • [22] Therapeutic goals in the treatment of Fabry disease
    Mehta, Atul
    West, Michael L.
    Pintos-Morell, Guillem
    Reisin, Ricardo
    Nicholls, Kathy
    Figuera, Luis E.
    Parini, Rossella
    Carvalho, Luiz R.
    Kampmann, Christoph
    Pastores, Gregory M.
    Lidove, Olivier
    GENETICS IN MEDICINE, 2010, 12 (11) : 713 - 720
  • [23] Enzyme replacement therapy for Fabry disease: A systematic review and meta-analysis
    Alegra, Taciane
    Vairo, Filippo
    de Souza, Monica V.
    Krug, Barbara C.
    Schwartz, Ida V. D.
    GENETICS AND MOLECULAR BIOLOGY, 2012, 35 (04) : 947 - 954
  • [24] Progress in the understanding and treatment of Fabry disease
    Miller, James J.
    Kanack, Adam J.
    Dahms, Nancy M.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2020, 1864 (01):
  • [25] Non-clinical evaluation of JR-051 as a biosimilar to agalsidase beta for the treatment of Fabry disease
    Morimoto, Hideto
    Ito, Yae
    Yoden, Eiji
    Horie, Masato
    Tanaka, Noboru
    Komurasaki, Yoshikazu
    Yamamoto, Ryuji
    Mihara, Kazutoshi
    Minami, Kohtaro
    Hirato, Tohru
    MOLECULAR GENETICS AND METABOLISM, 2018, 125 (1-2) : 153 - 160
  • [26] Fabry-Anderson disease: current state of knowledge
    Vega-Vega, Olynka
    Perez-Gutierrez, Angelica
    Correa-Rotter, Ricardo
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2011, 63 (03): : 314 - 321
  • [27] Fabry Disease Cardiac Manifestations and Therapeutic Options
    Pierre-Louis, Bredy
    Kumar, Anil
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2009, 17 (01) : 31 - 35
  • [28] Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion
    Guest, Julian F.
    Jenssen, Trond
    Houge, Gunnar
    Aaseboe, Willy
    Tondel, Camilla
    Svarstad, Einar
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (12) : 1104 - 1112
  • [29] Influence of Treatment Effect Modifiers in Fabry Disease: A Systematic Literature Review
    Azimpour, Khashayar
    Tordoff-Gibson, Carla
    Dorling, Patricia
    Koulinska, Irene
    Kunduri, Swati
    Laliman-Khara, Victor
    Forsythe, Anna
    ADVANCES IN THERAPY, 2025, 42 (02) : 579 - 596
  • [30] Treatment of Fabry Disease: Established and Emerging Therapies
    Umer, Muhammad
    Kalra, Dinesh K. K.
    PHARMACEUTICALS, 2023, 16 (02)
12345